{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,6]],"date-time":"2026-10-06T21:50:26Z","timestamp":1791323426303,"version":"4.3.1"},"reference-count":23,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2019,12,1]],"date-time":"2019-12-01T00:00:00Z","timestamp":1575158400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2019,12,1]],"date-time":"2019-12-01T00:00:00Z","timestamp":1575158400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/100006108","name":"National Center for Advancing Translational Sciences","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100006108","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Regulatory Toxicology and Pharmacology"],"published-print":{"date-parts":[[2019,12]]},"DOI":"10.1016\/j.yrtph.2019.104483","type":"journal-article","created":{"date-parts":[[2019,9,30]],"date-time":"2019-09-30T12:05:50Z","timestamp":1569845150000},"page":"104483","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":27,"special_numbering":"C","title":["Preclinical toxicity evaluation of JD5037, a peripherally restricted CB1 receptor inverse agonist, in rats and dogs for treatment of nonalcoholic steatohepatitis"],"prefix":"10.1016","volume":"109","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-7010-2630","authenticated-orcid":false,"given":"Vijay Pralhad","family":"Kale","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Seth","family":"Gibbs","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"John A.","family":"Taylor","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Amy","family":"Zmarowski","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Joseph","family":"Novak","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kristin","family":"Patton","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Barney","family":"Sparrow","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jenni","family":"Gorospe","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Satheesh","family":"Anand","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Resat","family":"Cinar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"George","family":"Kunos","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Robert J.","family":"Chorvat","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pramod S.","family":"Terse","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"2","key":"10.1016\/j.yrtph.2019.104483_bib1","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1111\/j.1527-3458.2006.00091.x","article-title":"Efficacy of rimonabant and other cannabinoid cb1 receptor antagonists in reducing food intake and body weight: preclinical and clinical data","volume":"12","author":"Carai","year":"2006","journal-title":"CNS Drug Rev."},{"issue":"3","key":"10.1016\/j.yrtph.2019.104483_bib2","doi-asserted-by":"crossref","first-page":"269","DOI":"10.1021\/js960085v","article-title":"Physicochemical and physiological mechanisms for the effects of food on drug absorption: the role of lipids and ph","volume":"86","author":"Charman","year":"1997","journal-title":"J. Pharm. Sci."},{"key":"10.1016\/j.yrtph.2019.104483_bib3","doi-asserted-by":"crossref","first-page":"707","DOI":"10.3389\/fphar.2017.00707","article-title":"Novel peripherally restricted cannabinoid 1 receptor selective antagonist txx-522 with prominent weight-loss efficacy in diet induced obese mice","volume":"8","author":"Chen","year":"2017","journal-title":"Front. Pharmacol."},{"issue":"17","key":"10.1016\/j.yrtph.2019.104483_bib4","doi-asserted-by":"crossref","first-page":"4751","DOI":"10.1016\/j.bmcl.2013.06.066","article-title":"Peripherally restricted cb1 receptor blockers","volume":"23","author":"Chorvat","year":"2013","journal-title":"Bioorg. Med. Chem. Lett"},{"issue":"19","key":"10.1016\/j.yrtph.2019.104483_bib5","doi-asserted-by":"crossref","first-page":"6173","DOI":"10.1016\/j.bmcl.2012.08.004","article-title":"Jd-5006 and jd-5037: peripherally restricted (pr) cannabinoid-1 receptor blockers related to slv-319 (ibipinabant) as metabolic disorder therapeutics devoid of cns liabilities","volume":"22","author":"Chorvat","year":"2012","journal-title":"Bioorg. Med. Chem. Lett"},{"issue":"1","key":"10.1016\/j.yrtph.2019.104483_bib6","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1002\/hep.26606","article-title":"Hepatic cannabinoid-1 receptors mediate diet-induced insulin resistance by increasing de novo synthesis of long-chain ceramides","volume":"59","author":"Cinar","year":"2014","journal-title":"Hepatology"},{"key":"10.1016\/j.yrtph.2019.104483_bib7","series-title":"Guide for the Care and Use of Laboratory Animals","author":"Council","year":"2011"},{"issue":"4","key":"10.1016\/j.yrtph.2019.104483_bib8","doi-asserted-by":"crossref","first-page":"342","DOI":"10.1002\/jat.1592","article-title":"Impact of gavage dosing procedure and gastric content on adverse respiratory effects and mortality in rat toxicity studies","volume":"31","author":"Eichenbaum","year":"2011","journal-title":"J. Appl. Toxicol."},{"issue":"1","key":"10.1016\/j.yrtph.2019.104483_bib9","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1111\/j.1748-5827.2009.00820.x","article-title":"Emesis in dogs: a review","volume":"51","author":"Elwood","year":"2010","journal-title":"J. Small Anim. Pract."},{"issue":"1","key":"10.1016\/j.yrtph.2019.104483_bib10","doi-asserted-by":"crossref","first-page":"172","DOI":"10.1177\/0192623316677327","article-title":"Sex differences in human and animal toxicology","volume":"45","author":"Gochfeld","year":"2017","journal-title":"Toxicol. Pathol."},{"issue":"5","key":"10.1016\/j.yrtph.2019.104483_bib11","doi-asserted-by":"crossref","first-page":"495","DOI":"10.1111\/dom.12447","article-title":"A novel peripheral cannabinoid receptor 1 antagonist, bpr0912, reduces weight independently of food intake and modulates thermogenesis","volume":"17","author":"Hsiao","year":"2015","journal-title":"Diabetes Obes. Metab."},{"issue":"1","key":"10.1016\/j.yrtph.2019.104483_bib12","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1111\/j.1748-1716.2011.02402.x","article-title":"Cb1 receptor antagonists: New discoveries leading to new perspectives","volume":"205","author":"Kirilly","year":"2012","journal-title":"Acta Physiol."},{"issue":"3","key":"10.1016\/j.yrtph.2019.104483_bib13","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1007\/s11095-017-2289-x","article-title":"Lipids in the stomach - implications for the evaluation of food effects on oral drug absorption","volume":"35","author":"Koziolek","year":"2018","journal-title":"Pharm. Res."},{"issue":"5","key":"10.1016\/j.yrtph.2019.104483_bib14","doi-asserted-by":"crossref","first-page":"863","DOI":"10.1038\/ijo.2008.3","article-title":"Effects of rimonabant, a cannabinoid cb1 receptor ligand, on energy expenditure in lean rats","volume":"32","author":"Kunz","year":"2008","journal-title":"Int. J. Obes."},{"issue":"5","key":"10.1016\/j.yrtph.2019.104483_bib15","doi-asserted-by":"crossref","first-page":"515","DOI":"10.1080\/01926230600978458","article-title":"Histopathology of the thymus","volume":"34","author":"Pearse","year":"2006","journal-title":"Toxicol. Pathol."},{"key":"10.1016\/j.yrtph.2019.104483_bib16","doi-asserted-by":"crossref","DOI":"10.1155\/2011\/432607","article-title":"Rimonabant: from rio to ban","volume":"2011","author":"Sam","year":"2011","journal-title":"J. Obes."},{"issue":"4","key":"10.1016\/j.yrtph.2019.104483_bib17","doi-asserted-by":"crossref","first-page":"1392","DOI":"10.1002\/hep.27678","article-title":"Challenges and opportunities in drug and biomarker development for nonalcoholic steatohepatitis: Findings and recommendations from an american association for the study of liver diseases-u.S. Food and drug administration joint workshop","volume":"61","author":"Sanyal","year":"2015","journal-title":"Hepatology"},{"issue":"3","key":"10.1016\/j.yrtph.2019.104483_bib18","doi-asserted-by":"crossref","first-page":"592","DOI":"10.1016\/j.drudis.2018.01.029","article-title":"Peripheral modulation of the endocannabinoid system in metabolic disease","volume":"23","author":"Shrestha","year":"2018","journal-title":"Drug Discov. Today"},{"issue":"3","key":"10.1016\/j.yrtph.2019.104483_bib19","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1016\/S0022-2275(20)36723-7","article-title":"Fatty acid binding to plasma albumin","volume":"16","author":"Spector","year":"1975","journal-title":"J. Lipid Res."},{"issue":"2","key":"10.1016\/j.yrtph.2019.104483_bib20","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1016\/j.cmet.2012.07.002","article-title":"Peripheral cannabinoid-1 receptor inverse agonism reduces obesity by reversing leptin resistance","volume":"16","author":"Tam","year":"2012","journal-title":"Cell Metabol."},{"issue":"10","key":"10.1016\/j.yrtph.2019.104483_bib21","doi-asserted-by":"crossref","first-page":"1113","DOI":"10.1016\/j.molmet.2017.06.010","article-title":"Peripheral cannabinoid-1 receptor blockade restores hypothalamic leptin signaling","volume":"6","author":"Tam","year":"2017","journal-title":"Mol. Metab."},{"key":"10.1016\/j.yrtph.2019.104483_bib22","doi-asserted-by":"crossref","first-page":"649","DOI":"10.1146\/annurev-pharmtox-010617-052545","article-title":"Nonalcoholic steatohepatitis (nash) and hepatic fibrosis: emerging therapies","volume":"58","author":"Wattacheril","year":"2018","journal-title":"Annu. Rev. Pharmacol. Toxicol."},{"issue":"10","key":"10.1016\/j.yrtph.2019.104483_bib23","doi-asserted-by":"crossref","first-page":"5780","DOI":"10.1073\/pnas.96.10.5780","article-title":"Increased mortality, hypoactivity, and hypoalgesia in cannabinoid cb1 receptor knockout mice","volume":"96","author":"Zimmer","year":"1999","journal-title":"Proc. Natl. Acad. Sci. U. S. A."}],"container-title":["Regulatory Toxicology and Pharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0273230019302478?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0273230019302478?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,3]],"date-time":"2025-10-03T12:28:05Z","timestamp":1759494485000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0273230019302478"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,12]]},"references-count":23,"alternative-id":["S0273230019302478"],"URL":"https:\/\/doi.org\/10.1016\/j.yrtph.2019.104483","relation":{},"ISSN":["0273-2300"],"issn-type":[{"value":"0273-2300","type":"print"}],"subject":[],"published":{"date-parts":[[2019,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Preclinical toxicity evaluation of JD5037, a peripherally restricted CB1 receptor inverse agonist, in rats and dogs for treatment of nonalcoholic steatohepatitis","name":"articletitle","label":"Article Title"},{"value":"Regulatory Toxicology and Pharmacology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.yrtph.2019.104483","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2019 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"104483"}}